Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 21, 2017
Total Value: $170M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES | 880,000 | $24.68M | 14.5% | $27.77 | — | COM | 09627Y109 |
| AXGN | AXOGEN INC | 1,970,000 | $17.73M | 10.4% | $3.33 | +159.0% | COM | 05463X106 |
| — | ARIAD PHARMACEUTICALS INC | 1,000,000 | $12.44M | 7.3% | $6983.72 | — | COM | 04033A100 |
| — | AEVI GENOMIC MEDICINE INC | 1,500,000 | $7.77M | 4.6% | $5.18 | — | COM | 00835P105 |
| — | FIBROGEN INC | 330,000 | $7.062M | 4.2% | $25.62 | — | COM | 31572Q808 |
| — | FOAMIX PHARMACEUTICALS LTD | 495,000 | $5.495M | 3.2% | $7.68 | — | SHS | M46135105 |
| AGIO | AGIOS PHARMACEUTICALS | 130,000 | $5.425M | 3.2% | $43.03 | +21.9% | COM | 00847X104 |
| CDXS | CODEXIS INC | 1,170,000 | $5.382M | 3.2% | $1.98 | +136.5% | COM | 192005106 |
| — | CHIMERIX INC | 1,170,000 | $5.382M | 3.2% | $4.98 | — | COM | 16934W106 |
| — | AQUINOX PHARMACEUTICALS INC | 310,000 | $5.118M | 3.0% | $6.95 | — | COM | 03842B101 |
| TBPH | THERAVANCE BIOPHARMA INC | 158,200 | $5.043M | 3.0% | $31.02 | 0.0% | ORD SHS | G8807B106 |
| — | MOMENTA PHARMACEUTICALS INC | 330,000 | $4.967M | 2.9% | $15.05 | — | COM | 60877T100 |
| — | ADAMAS PHARMACEUTICALS INC | 285,000 | $4.817M | 2.8% | $18.63 | — | COM | 00548A106 |
| — | CARA THERAPEUTICS | 475,000 | $4.413M | 2.6% | $8.65 | — | COM | 140755109 |
| PRTA | PROTHENA CORP PLC | 82,500 | $4.058M | 2.4% | $54.25 | +1.7% | SHS | G72800108 |
| — | LOXO ONCOLOGY | 125,000 | $4.014M | 2.4% | $26.89 | — | COM | 548862101 |
| EGRX | EAGLE PHARMACEUTICALS INC | 50,000 | $3.967M | 2.3% | $67.25 | +8.0% | COM | 269796108 |
| — | EDGE THERAPEUTICS INC | 280,000 | $3.5M | 2.1% | $9.54 | — | COM | 279870109 |
| MGNX | MACROGENICS INC | 170,000 | $3.475M | 2.0% | $24.33 | +3.4% | COM | 556099109 |
| XENE | XENON PHARMACEUTICALS INC | 405,000 | $3.119M | 1.8% | $8.69 | -7.6% | COM | 98420N105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 90,000 | $3.015M | 1.8% | $28.66 | 0.0% | COM | 29251M106 |
| — | STRONGBRIDGE BIOPHARMA PLC | 1,160,000 | $2.784M | 1.6% | $2.40 | — | ORD SHS | G85347105 |
| OMER | OMEROS CORP | 265,300 | $2.632M | 1.6% | $10.20 | 0.0% | COM | 682143102 |
| — | CLEARSIDE BIOMEDICAL INC | 270,000 | $2.414M | 1.4% | $8.94 | — | COM | 185063104 |
| — | LION BIOTECHNOLOGIES INC | 300,000 | $2.085M | 1.2% | $8.03 | — | COM | 53619R102 |
| — | ABEONA THERAPEUTICS INC | 400,000 | $1.94M | 1.1% | $5.14 | — | COM | 00289Y107 |
| CTMX | CYTOMX THERAPEUTICS INC | 170,000 | $1.868M | 1.1% | $11.45 | +5.8% | COM | 23284F105 |
| — | PROTEOSTASIS THERAPEUTICS INC | 150,000 | $1.839M | 1.1% | $13.20 | — | COM | 74373B109 |
| — | IMPRIMIS PHARMACEUTICALS INC | 720,000 | $1.8M | 1.1% | $2946.31 | — | COM NEW | 45323A201 |
| — | SAGE THERAPEUTICS INC | 35,000 | $1.787M | 1.1% | $51.06 | — | COM | 78667J108 |
| — | NEURODERM LTD | 115,000 | $1.731M | 1.0% | $16.26 | — | ORD SHS | M74231107 |
| — | WAFERGEN BIO-SYSTEMS INC | 320,000 | $1.578M | 0.9% | $4.93 | — | COM | 93041P506 |
| — | CORIUM INTERNATIONAL INC | 380,000 | $1.543M | 0.9% | $7.82 | — | COM | 21887L107 |
| SGMO | SANGAMO BIOSCIENCES INC | 400,000 | $1.22M | 0.7% | $3.64 | 0.0% | COM | 800677106 |
| — | ACHAOGEN INC | 80,000 | $1.041M | 0.6% | $13.01 | — | COM | 004449104 |
| — | PROTALIX BIOTHERAPEUTICS INC | 1,930,000 | $859K | 0.5% | $1.32 | — | COM | 74365AAB7 |
| OCUL | OCULAR THERAPEUTIX INC | 93,600 | $783K | 0.5% | $7.76 | 0.0% | COM | 67576A100 |
| — | TRILLIUM THERAPEUTICS INC | 110,000 | $622K | 0.4% | $9.00 | — | COM NEW | 89620X506 |
| — | BIOLINERX LTD | 250,000 | $230K | 0.1% | $1426.15 | — | SPONSORED ADR | 09071M106 |
| — | AGILE THERAPEUTICS INC | 15,000 | $85,000 | 0.1% | $5.67 | — | COM | 00847L100 |